A technology company leading the adoption of AI to advance precision medicine and patient care, today announced the expansion of its care pathway intelligence platform, Tempus Next, into breast cancer. Since its launch in 2024, Tempus Next has screened thousands of…
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), an AI-powered biotherapeutics company, today announced the appointment of Jon Lieber to its Board of Directors, effective immediately. Mr. Lieber has over 30 years of financial and strategic leadership experience in…
AI Platform Evidently Announces Partnership With Allina Health Clinical data intelligence platform Evidently is announcing an extended partnership with Allina Health, under which Evidently’s AI system will process millions of patient encounters each year to reduce clinicians’ cognitive workloads while elevating quality…
A pioneer in cardiac treatment for microvascular disease, today announced that the U.S. Food & Drug Administration (FDA) has granted its technology an Investigational Use Exemption (IDE), allowing the pivotal clinical trial to begin in U.S. hospitals. CorFlow will now…
OnMed, the nation’s leading hybrid healthcare tech company, continues to transform the way people access care, with two new OnMed CareStations launching this July at Fiesta Mart locations in Fort Worth and Missouri City. The Fort Worth CareStation is made…
Twist Bioscience Corporation, a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today accelerated its Express turnaround time for all Twist Gene Fragments with a turnaround time starting at two business days for…
A world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the company’s leadership position in the clinical research industry, cutting-edge innovation, its efforts in inclusion and…
After two years away from the spotlight, Lewis Capaldi broke the silence and made a courageous return to music with his new single “Survive” – a bold, brave anthem that addresses a challenging period in his career that peaked at Glastonbury in…
CorFlow Therapeutics AG a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S. Food & Drug Administration (FDA) has approved the company’s technology for investigational device exemption (IDE), which allows the pivotal clinical trial…
A technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, proudly recognizes DAB Transport’s outstanding commitment to service central Georgia with compassion and flexibility. Founded in 2020 by Regina Mcrae, a…
Haleon Begins Construction on £130M Global Oral Health Innovation Centre This week, Haleon, a global leader in consumer health and maker of leading brands such as Sensodyne, parodontax and Polident, broke ground on its new Global Oral Health Innovation Centre…
The “Global Sickle Cell Disease Treatment Market: Focus on Type, End User, and Country-Level Analysis – Analysis and Forecast, 2025-2035″ report has been added to ResearchAndMarkets.com’s offering. The global sickle cell disease treatment market is expected to experience substantial growth, driven by the increasing…